ArticleActa pharmaceutica Sinica. B2023

A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants.

Shugang Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.